Michal Abraham

2.3k total citations
46 papers, 1.8k citations indexed

About

Michal Abraham is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, Michal Abraham has authored 46 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 27 papers in Immunology and 17 papers in Hematology. Recurrent topics in Michal Abraham's work include Chemokine receptors and signaling (21 papers), Immunotherapy and Immune Responses (19 papers) and Multiple Myeloma Research and Treatments (12 papers). Michal Abraham is often cited by papers focused on Chemokine receptors and signaling (21 papers), Immunotherapy and Immune Responses (19 papers) and Multiple Myeloma Research and Treatments (12 papers). Michal Abraham collaborates with scholars based in Israel, United States and Switzerland. Michal Abraham's co-authors include Amnon Peled, Katia Beider, Hanna Wald, Eithan Galun, Arnon Nagler, Howard L. Weiner, Ido D. Weiss, Ori Wald, Arnon Karni and Ariel Miller and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Michal Abraham

45 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michal Abraham Israel	26	975	724	438	431	181	46	1.8k
Manjula Reddy United States	23	840 0.9×	719 1.0×	276 0.6×	737 1.7×	168 0.9×	39	2.0k
Katia Beider Israel	26	1.1k 1.1×	1.2k 1.6×	473 1.1×	667 1.5×	88 0.5×	62	2.2k
Alessandra Mancino Italy	13	1.1k 1.1×	718 1.0×	221 0.5×	562 1.3×	116 0.6×	17	1.9k
Lisa G. M. van Baarsen Netherlands	31	1.4k 1.4×	615 0.8×	295 0.7×	572 1.3×	380 2.1×	76	3.1k
Fumihiko Kimura Japan	21	781 0.8×	438 0.6×	520 1.2×	700 1.6×	135 0.7×	138	2.1k
Omar Perbellini Italy	22	922 0.9×	427 0.6×	291 0.7×	327 0.8×	207 1.1×	50	1.9k
Martine Chabaud France	10	1.6k 1.7×	664 0.9×	413 0.9×	482 1.1×	214 1.2×	12	2.6k
Prabhakar Putheti United States	19	993 1.0×	281 0.4×	291 0.7×	326 0.8×	120 0.7×	35	1.9k
Birgitte Oppers‐Walgreen Netherlands	15	1.5k 1.5×	647 0.9×	320 0.7×	654 1.5×	160 0.9×	17	2.5k

Countries citing papers authored by Michal Abraham

Since Specialization

Citations

This map shows the geographic impact of Michal Abraham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Abraham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Abraham more than expected).

Fields of papers citing papers by Michal Abraham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Abraham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Abraham. The network helps show where Michal Abraham may publish in the future.

Co-authorship network of co-authors of Michal Abraham

This figure shows the co-authorship network connecting the top 25 collaborators of Michal Abraham. A scholar is included among the top collaborators of Michal Abraham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Abraham. Michal Abraham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hagbi-Levi, Shira, Michal Abraham, Ori Wald, et al.. (2025). Identification of Dinaciclib and Ganetespib as anti-inflammatory drugs using a novel HTP screening assay that targets IFNγ-dependent PD-L1. Frontiers in Immunology. 16. 1502094–1502094.

Abraham, Michal, Inbal Mishalian, Tamar Katz, et al.. (2020). Brief ex vivo Fas-ligand incubation attenuates GvHD without compromising stem cell graft performance. Bone Marrow Transplantation. 55(7). 1305–1316. 2 indexed citations

Beider, Katia, Hila Magen, Jonathan Canaani, et al.. (2019). The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulators. Biochemical Pharmacology. 168. 412–428. 14 indexed citations

Peled, Amnon, Shiri Klein, Katia Beider, Jan A. Burger, & Michal Abraham. (2018). Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies. Cytokine. 109. 11–16. 69 indexed citations

Abraham, Michal, Yaron Pereg, Baruch Bulvik, et al.. (2017). Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34+ Cells in Healthy Volunteers. Clinical Cancer Research. 23(22). 6790–6801. 41 indexed citations

Klein, Shiri, Michal Abraham, Baruch Bulvik, et al.. (2017). CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1–Mediated ERK and BCL2/Cyclin D1 Pathways. Cancer Research. 78(6). 1471–1483. 48 indexed citations

Abraham, Michal, Arnon Karni, Karin Mausner-Fainberg, Ido D. Weiss, & Amnon Peled. (2017). Natural and induced immunization against CCL20 ameliorate experimental autoimmune encephalitis and may confer protection against multiple sclerosis. Clinical Immunology. 183. 316–324. 6 indexed citations

Abraham, Michal, Shiri Klein, Baruch Bulvik, et al.. (2017). The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression. Leukemia. 31(11). 2336–2346. 86 indexed citations

Beider, Katia, Avichai Shimoni, Merav Leiba, et al.. (2016). The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 Pathway. Clinical Cancer Research. 23(7). 1733–1747. 33 indexed citations

10.

Weiss, Ido D., Ezra Ella, Yoav Smith, et al.. (2015). In the Hunt for Therapeutic Targets: Mimicking the Growth, Metastasis, and Stromal Associations of Early-Stage Lung Cancer Using a Novel Orthotopic Animal Model. Journal of Thoracic Oncology. 10(1). 46–58. 15 indexed citations

11.

Beider, Katia, Merav Darash‐Yahana, Maya Koren‐Michowitz, et al.. (2014). Combination of Imatinib with CXCR4 Antagonist BKT140 Overcomes the Protective Effect of Stroma and Targets CML In Vitro and In Vivo. Molecular Cancer Therapeutics. 13(5). 1155–1169. 51 indexed citations

12.

Peled, Amnon, Michal Abraham, Irit Avivi, et al.. (2013). The High-Affinity CXCR4 Antagonist BKT140 Is Safe and Induces a Robust Mobilization of Human CD34+ Cells in Patients with Multiple Myeloma. Clinical Cancer Research. 20(2). 469–479. 70 indexed citations

13.

Beider, Katia, Elena Ribakovsky, Michal Abraham, et al.. (2013). Targeting the CD20 and CXCR4 Pathways in Non-Hodgkin Lymphoma with Rituximab and High-Affinity CXCR4 Antagonist BKT140. Clinical Cancer Research. 19(13). 3495–3507. 48 indexed citations

14.

Barashi, Neta, Ido D. Weiss, Ori Wald, et al.. (2013). Inflammation-Induced Hepatocellular Carcinoma Is Dependent on Ccr5 in Mice. Hepatology. 58(3). 1021–1030. 59 indexed citations

15.

Weiss, Ido D., Michal Abraham, Katia Beider, et al.. (2012). In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non–small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery. 144(5). 1167–1175.e1. 56 indexed citations

16.

Weiss, Ido D., Ori Wald, Hanna Wald, et al.. (2010). IFN-γ Treatment at Early Stages of Influenza Virus Infection Protects Mice from Death in a NK Cell-Dependent Manner. Journal of Interferon & Cytokine Research. 30(6). 439–449. 80 indexed citations

17.

Abraham, Michal, Katia Beider, Hanna Wald, et al.. (2009). The CXCR4 antagonist 4F-benzoyl-TN14003 stimulates the recovery of the bone marrow after transplantation. Leukemia. 23(8). 1378–1388. 33 indexed citations

18.

Beider, Katia, Michal Abraham, Hanna Wald, et al.. (2009). Interaction between CXCR4 and CCL20 Pathways Regulates Tumor Growth. PLoS ONE. 4(4). e5125–e5125. 64 indexed citations

19.

Abraham, Michal, Arnon Karni, Ariel Miller, et al.. (2008). In vitro induction of regulatory T cells by anti-CD3 antibody in humans. Journal of Autoimmunity. 30(1-2). 21–28. 39 indexed citations

20.

Karni, Arnon, Michal Abraham, Alon Monsonego, et al.. (2006). Innate Immunity in Multiple Sclerosis: Myeloid Dendritic Cells in Secondary Progressive Multiple Sclerosis Are Activated and Drive a Proinflammatory Immune Response. The Journal of Immunology. 177(6). 4196–4202. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact